MedPath

The effect and safety of TJ-14 adverse event associated autologous peripheral blood stem cell transplantation for multiple myeloma

Phase 2
Conditions
multiple myeloma
Registration Number
JPRN-UMIN000034975
Lead Sponsor
Hitachi general hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
10
Inclusion Criteria

Not provided

Exclusion Criteria

Uncontrolled active infection. Active gastrointestinal ulcer. Uncontrolled diabetes mellitus. Serious psychiatric illness. Patient who is judged to be medically unfit by physician.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath